Dissemination and Evolution of Multidrug-Resistant Gram-Negative Bacterial Pathogens
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 291
Special Issue Editor
Interests: antibiotic resistance; microbiology; antibiotics; bacterial antibiotic resistance; bacteriology; antimicrobial resistance; antibacterial activity; general microbiology; microbial isolation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The uninterrupted evolution of antimicrobial resistance has become a global epidemic. The antimicrobial resistance epidemic causes millions of deaths worldwide attributable to and associated with this phenomenon.
Among the leading bacterial pathogens associated with multidrug resistance are four Gram-negative bacteria: Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa. The antimicrobial resistance pandemic is compounded by the lack of antibiotics for the appropriate treatment of infections caused by multidrug-resistant Gram-negative bacteria. Gram-negative pathogens, e.g., Acinetobacter baumannii, disseminate readily in hospitals. The population predominantly affected includes the immunosuppressed, patients with comorbidities, the frail and elderly, and patients treated in intensive care units. The antibiotic resistance problem is a present danger, and all involved must confront it, i.e., clinicians, researchers, hospitals, the government, and individuals.
Dr. Eduardo Rodríguez-Noriega
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gram-negative bacteria
- multidrug-resistant
- antimicrobial resistance
- Escherichia coli
- Klebsiella pneumoniae
- Acinetobacter baumannii
- Pseudomonas aeruginosa
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
